Anesthetic Considerations for Repeat Cesarean Section - a Prospective Study
Sponsor
Shaare Zedek Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04693572
Collaborator
(none)
1,500
11
Study Details
Study Description
Brief Summary
The purpose of this study is to examine the anesthetic considerations and outcomes during repeated caesarean section and to compare such considerations in low-order vs high-order repeated caesarean sections.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
Data concerning anesthetic considerations and outcomes will be gathered from the electronic medical records of all parturients undergoing repeated caesarean sections in our medical center. the collected data will be stored anonymously.
Different aspects of anesthetic considerations and outcomes will be compared and subjected to analysis.
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
1500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Anesthetic Considerations for Repeat Cesarean Section - a Prospective Study
Anticipated Study Start Date
:
Jan 1, 2021
Anticipated Primary Completion Date
:
Dec 1, 2021
Anticipated Study Completion Date
:
Dec 1, 2021
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Parturients undergoing repeated caesarean sectiona
|
Outcome Measures
Primary Outcome Measures
- Percentage of sections performed under general anesthesia [1 day]
- Percentage of in-surgery conversion from regional to general anesthesia [1 day]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Parturients undergoing repeated caesarean section.
Exclusion Criteria:
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Shaare Zedek Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Jacob Weinstein, MD MSc,
Clinical Fellow,
Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
NCT04693572
Other Study ID Numbers:
- 0415-20-SZMC
First Posted:
Jan 5, 2021
Last Update Posted:
Jan 5, 2021
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jacob Weinstein, MD MSc,
Clinical Fellow,
Shaare Zedek Medical Center